Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
Nicole D. Armstrong(University of Alabama at Birmingham), James A. McCubrey(East Carolina University), Roberta Maestro(Centro di Riferimento Oncologico), Lucio Cocco(University of Bologna), Antonino B. D’Assoro(Mayo Clinic), Kristin M. Stadelman(East Carolina University), Alberto M. Martelli(University of Bologna), Agnieszka Gizak(University of Wrocław), Sanja Mijatović(University of Belgrade), Piotr Laidler(Jagiellonian University), Л. Б. Дробот(Palladin Institute of Biochemistry), Dariusz Rakus(University of Wrocław), Joerg Basecke(University of Göttingen), Melissa L. Sokolosky(East Carolina University), Melchiorre Cervello(Foundation for Biomedical Research), Saverio Candido(University of Catania), Giuseppe Montalto(University of Palermo), Joanna Dulińska-Litewka(Jagiellonian University), Zoya N. Demidenko(Roswell Park Comprehensive Cancer Center), Jerry Polesel(Centro di Riferimento Oncologico), Danijela Maksimović‐Ivanić(Institute for Biological Research “Siniša Stanković”), Timothy L. Fitzgerald(East Carolina University), Ferdinando Nicoletti(University of Catania), Stephen L. Abrams(East Carolina University), Linda S. Steelman(East Carolina University), Massimo Libra(University of Catania)
Cited by 246
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857